Lamisil

Terbinafine Hydrochloride, the active ingredient in Lamisil, is an allylamine antifungal presented as a topical formulation for skin application. It treats dermatophyte infections such as athlete's foot, jock itch, ringworm, and superficial nail fungus in both adults and children.

GNH USA supplies Lamisil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Lamisil (terbinafine) is used to treat fungal skin infections caused by dermatophytes.

- Tinea pedis (athlete's foot): reduces itching, scaling and erythema while eradicating the causative fungus. - Tinea cruris (jock itch): relieves irritation and clears the infection in the groin area. - Tinea corporis (ringworm): eliminates lesions and prevents spread across the body. - Tinea unguium (onychomycosis – topical use): improves nail appearance by reducing fungal growth on the nail surface.

Lamisil is generally well tolerated, but local reactions can occur.

Common Side Effects: - Itching: mild to moderate sensation at the application site. - Burning: transient heat sensation during or after application. - Redness: localized erythema around the treated area. - Scaling: flaking of skin as the infection resolves. - Stinging: brief sharp discomfort upon contact. - Dry skin: temporary dryness where the product is applied.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing, or hives. - Stevens‑Johnson syndrome: widespread skin blistering and mucosal involvement. - Contact dermatitis: intense rash or swelling at the site. - Bullous pemphigoid‑like eruption: blister formation on the skin. - Liver enzyme elevation (systemic absorption): abnormal liver function tests. - Phototoxic reaction: heightened skin sensitivity to sunlight.

Before using Lamisil, consider the following safety measures.

- Avoid use on broken or inflamed skin: may increase irritation. - Discontinue if infection persists beyond two weeks: seek medical advice. - Do not apply to eyes or mucous membranes: can cause severe irritation. - Keep away from children: store out of reach to prevent accidental ingestion. - Wash hands after application: reduces risk of inadvertent contact with other areas. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Lamisil has limited systemic interaction potential, but certain combinations warrant attention.

Major Interactions (Avoid): - Concurrent systemic terbinafine therapy: may lead to excessive systemic exposure. - Use with other topical antifungals containing azoles: increased risk of skin irritation.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: may mask infection signs. - Use under occlusive dressings: can enhance drug absorption and irritation. - Combination with irritant skin products (e.g., exfoliants): may exacerbate local reactions.